Related Experiment Video

Updated: May 30, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Transcatheter aortic valve implantation: the new option for high-risk patients with aortic stenosis

Anna Olasińska-Wiśniewska1, Marek Grygier, Maciej Lesiak

  • 11st Department of Cardiology, Poznan University of Medical Sciences, ul. Dluga 1/2, Poznan, Poland. anna.olasinska@poczta.onet.pl

Cardiology Journal
|July 20, 2011
PubMed

Insights

Calcific aortic valve stenosis is a common heart condition. Transcatheter aortic valve implantation (TAVI) offers a promising alternative treatment for patients with severe aortic stenosis who are at high risk for traditional surgery.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Calcific aortic valve stenosis is the most prevalent valvular heart disease in developed nations.
  • Severe symptomatic aortic valve stenosis typically requires surgical aortic valve replacement for a positive prognosis.
  • Elderly patients with severe, symptomatic aortic stenosis are often denied surgery due to high perioperative risks.

Purpose of the Study:

  • To review transcatheter aortic valve implantation (TAVI) systems.
  • To identify patient populations who are suitable candidates for TAVI.
  • To discuss the benefits and drawbacks of the TAVI procedure.

Main Methods:

  • Review of current TAVI systems and technologies.
  • Analysis of patient selection criteria for TAVI.
  • Evaluation of clinical outcomes, advantages, and disadvantages of TAVI.

Main Results:

  • TAVI is an effective alternative for high-risk patients unsuitable for surgical valve replacement.
  • The review details various TAVI systems and their specific applications.
  • Key advantages and disadvantages of TAVI are presented for informed clinical decision-making.

Conclusions:

  • TAVI provides a vital treatment option for selected patients with severe symptomatic aortic stenosis.
  • Careful patient selection is crucial for optimizing TAVI outcomes.
  • Understanding the TAVI procedure's benefits and risks is essential for managing valvular heart disease.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...